Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,373 public trials 240 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Suspended

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

NCT03816319

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Northwestern University Chicago, Illinois, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States

View Trial Details

Suspended

DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial

NCT06492707

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Withdrawn

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

NCT07387354

Conditions: Bone Marrow Disease, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details